1Saslow D,Runowicz CD,Solomon D,et al.American Cancer Society Guideline for the early detection of cervical neoplasia and cancer.CA Cancer J Clin,2002,52 (6):342-362.
2Tewari KS,Kyshtoobayeva AS,Mehta RS,et al.Biomarker conservation in primary and metastatic epithelial ovarian cancer.Gynecol Oncol,2000,78(2):130-136.
3Menon U,Jacobs I.Recent developments in ovarian cancer screening.Curr Opin Obstet Gynecol,2000,12(1):39-42.
4Cohen LS,Escobar PF,Scharm C,et al.Three dimensional power Doppler ultrasound imp roves the diagnostic accuracy for ovarian cancer prediction.Gynecol Oncol,2001,82(1):40- 48.
5Smith RA,Cokkinides V,Eyre HJ.American cancer society Guidelines for the early detection of cancer.CA Cancer J Clin,2003,53(1):27-43.
6Merchant M,Weinberger SR.Recent advancements in surface enhanced laser desorption/i onization time of flight mass spectrometry.Electrophoresis,2000,21 (6):1164 - 1177.
7Li J,Zhang Z,Rosenzweig J,et al.Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.Clin Chem,2002,48(8):1296-1304.
8Cazares LH,Adam BL,Ward MD,et al.Normal,benign,preneoplastic and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ ionization mass spectrometry.Clin Cancer Res,2002,8(8):2541-2552.
9Vlahou A,Schellhammer PF,Mendrinos S,et al.Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine.Am J Pathol,2001,158(4):1491-1502.
10Petricoin EF,Ardekani AM,Hitt BA,et al.Use of proteomic patterns in serum to identify ovarian cancer.Lancet,2002,359(9306):572-577.
